Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines & 3rd Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts

 

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

Christopher Kirk Lippincott, M.D., M.P.H.

Headshot of Christopher Kirk Lippincott
  • Clinical Director, Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis
  • Assistant Professor of Medicine
Male

Expertise

Bronchiectasis, HIV/AIDS, Infectious Diseases, Lyme Disease, Mycobacterial lung disease, Tuberculosis ...read more

Request an Appointment

Insurance Information

Main Phone

410-583-2900

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

Johns Hopkins Medicine - Green Spring Station

Appointment Phone: 410-583-2900
10751 Falls Road
Falls Concourse Suite 412
Lutherville, MD 21093 map
Phone: 410-583-2900 | Fax: 410-583-2654

The Johns Hopkins Hospital

Appointment Phone: 410-583-2900
600 N. Wolfe Street
Baltimore, MD 21287 map
Fax: 410-583-2654

Background

Dr. Christopher K. Lippincott is an infectious diseases specialist at the Johns Hopkins University School of Medicine. He is the Clinical Director for the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis. He is an expert in the care of patients with mycobacterial infections (NTM and tuberculosis), HIV/AIDS, Lyme disease, and general infectious diseases. He provides teaching to medical students, residents and fellows at the Johns Hopkins University School of Medicine.

Dr. Lippincott earned his M.D. at the University of Virginia School of Medicine. He completed his residency at The Ohio State University Wexner Medical Center and infectious diseases fellowship at the University of North Carolina Hospitals. He also earned a Master of Public Health in epidemiology from the University of North Carolina at Chapel Hill in 2013. Prior to joining Johns Hopkins University in 2015, Dr. Lippincott practiced infectious diseases internationally for Medecins Sans Frontieres (Abkhazia, Georgia) and Right to Care (Johannesburg, South Africa).

Dr. Lippincott’s research interests include mycobacterial infections (NTM and tuberculosis) and bronchiectasis.

...read more

Titles

  • Clinical Director, Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis
  • Assistant Professor of Medicine

Departments / Divisions

Education

Degrees

  • MD; University of Virginia School of Medicine (2006)

Residencies

  • Internal Medicine; The Ohio State University Wexner Medical Center (2009)

Fellowships

  • Infectious Diseases; UNC Medical Center (2013)

Board Certifications

  • American Board of Internal Medicine (Infectious Disease) (2012)

Research & Publications

Selected Publications

Joseph SB, Kincer LP, Bowman NM, Evans C, Vinikoor MJ, Lippincott CK, Gisslén M, Spudich S, Menezes P, Robertson K, Archin N, Kashuba A, Eron JJ, Price RW, Swanstrom R. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells. Clin Infect Dis. 2019 Sep 27;69(8):1345-1352. doi: 10.1093/cid/ciy1066. PMID: 30561541; PMCID: PMC6938202

Berhanu RH, Schnippel K, Kularatne R, Firnhaber C, Jacobson KR, Horsburgh CR, Lippincott CK. Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia? Int J Tuberc Lung Dis. 2018 Aug 1;22(8):358-362. doi: 10.5588/ijtld.17.0837. PMID: 29991400; PMCID: PMC6421943

Lippincott CK, Miller MB, Van Rie A, Weber DJ, Sena AC, Stout JE. Complexities of Xpert MTB/RIF Interpretation. Int J Tuberc Lung Dis. 2015 Mar;19(3):273-275. PMID: 25686132

van Hougenhouck-Tulleken WG, Papavarnavas NS, Nel JS, Blackburn LY, Govender NP, Spencer DC, Lippincott CK. HIV-Associated Disseminated Emmonsiosis, Johannesburg, South Africa. Emerg Infect Dis. 2014 Dec;20(12):2164-6. PMID: 25417674

Lippincott CK, Miller MB, Popowitch EB, Hanrahan CF, Van Rie A. Xpert MTB/RIF Shortens Airborne Isolation for Hospitalized Patients with Presumptive Tuberculosis in the United States. Clin Infect Dis. 2014 Jul 15;59(2):186-92. PMID: 24729506

Is this you? Edit Profile
back to top button